Clinical Trial Update: Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) with Cemiplimab for locally advanced biliary tract cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Colorectal Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Libtayo (cemiplimab)

Snippet

Sponsor: Columbia University | Conditions: Colon and Rectal Cancer | Phase 2 | Status: RECRUITING